WHO Approves Emergency Use Listing for China’s Sinopharm CCP Virus Vaccine

WHO Approves Emergency Use Listing for China’s Sinopharm CCP Virus Vaccine
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus gestures during a daily press briefing on COVID-19 at the WHO headquarters in Geneva, Switzerland, on March 2, 2020. Fabrice Coffrini/AFP via Getty Images
Caden Pearson
Updated:

The World Health Organization (WHO) on Friday approved China’s state-owned Sinopharm CCP virus vaccine for emergency use for adults over 18.

This comes despite concerns raised by a separate group of WHO experts who said they had “very low confidence” regarding the risk of serious side-effects in some patients.

Related Topics